PLoS Pathogens (May 2019)

Human cytomegalovirus protein UL42 antagonizes cGAS/MITA-mediated innate antiviral response.

  • Yu-Zhi Fu,
  • Yi Guo,
  • Hong-Mei Zou,
  • Shan Su,
  • Su-Yun Wang,
  • Qing Yang,
  • Min-Hua Luo,
  • Yan-Yi Wang

DOI
https://doi.org/10.1371/journal.ppat.1007691
Journal volume & issue
Vol. 15, no. 5
p. e1007691

Abstract

Read online

Cyclic GMP-AMP synthase (cGAS) senses viral DNA in the cytosol and then catalyzes synthesis of the second messenger cGAMP, which activates the ER-localized adaptor protein Mediator of IRF3 Activator (MITA) to initiate innate antiviral response. Human cytomegalovirus (HCMV) proteins can antagonize host immune responses to promote latent infection. Here, we identified HCMV UL42 as a negative regulator of cGAS/MITA-dependent antiviral response. UL42-deficiency enhances HCMV-induced production of type I interferons (IFNs) and downstream antiviral genes. Consistently, wild-type HCMV replicates more efficiently than UL42-deficient HCMV. UL42 interacts with both cGAS and MITA. UL42 inhibits DNA binding, oligomerization and enzymatic activity of cGAS. UL42 also impairs translocation of MITA from the ER to perinuclear punctate structures, which is required for MITA activation, by facilitating p62/LC3B-mediated degradation of translocon-associated protein β (TRAPβ). These results suggest that UL42 can antagonize innate immune response to HCMV by targeting the core components of viral DNA-triggered signaling pathways.